HMGB1 and B-cell chronic lymphocytic leukemia: Increased plasma or serum levels of HMGB1 have been found in several cancers and higher circulating HMGB1 is associated with worse clinical outcomes in patients with CLL, colon carcinoma, or hepatocellular carcinoma20,45,46.